Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop

被引:125
作者
Zhang, J. [1 ]
Sun, Q.
Zhang, Z. [1 ]
Ge, S.
Han, Z-G [2 ]
Chen, W-T [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Dept Oral & Maxillofacial Surg,Peoples Hosp 9, Shanghai 200011, Peoples R China
[2] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
microRNA; miRNA-143/145; MDM2; p53; epithelial maligancies; MIR-143/145; CLUSTER; ANTI-ONCOMIRS; C-MYC; P53; EXPRESSION; ONCOPROTEIN; ACTIVATION; INDUCTION; MICRORNAS; ONCOGENE;
D O I
10.1038/onc.2012.28
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dysregulated microRNAs (miRNAs) have an important role in many malignant tumors. However, elucidating the roles of miRNAs in cancer biology, especially in epithelial cancers, remains an ongoing process. In this study, we show that both miR-143 and miR-145, which belong to the same miRNA cluster, can negatively modulate expression of their target gene, MDM2. The miR-143 and miR-145 is posttranscriptionally activated by upregulated p53, thereby generating a short miRNAs-MDM2-p53 feedback loop. Re-expression of these miRNAs suppresses cellular growth and triggers the apoptosis of epithelial cancer, in vitro and in vivo, by enhancing p53 activity via MDM2 turnover. Moreover, the miRNA-dependent MDM2 turnover contributes to the equilibrium of repeated p53 pulses in response to DNA damage stress. These findings suggest that MDM2 dysregulation caused by downregulation of miR-143 and miR-145 contributes to epithelial cancer development and has a key role in regulating cellular proliferation and apoptosis. Re-expression of miR-143 and miR-145 may be a reasonable strategy for treatment of epithelial cancers. Oncogene (2013) 32, 61-69; doi:10.1038/onc.2012.28; published online 13 February 2012
引用
收藏
页码:61 / 69
页数:9
相关论文
共 37 条
[31]   MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity [J].
Saha, Manujendra N. ;
Jiang, Hua ;
Jayakar, Jennifer ;
Reece, Donna ;
Branch, Donald R. ;
Chang, Hong .
CANCER BIOLOGY & THERAPY, 2010, 9 (11) :936-944
[32]   Traveling Bax and Forth from Mitochondria to Control Apoptosis [J].
Soriano, Maria Eugenia ;
Scorrano, Luca .
CELL, 2011, 145 (01) :15-17
[33]   Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation [J].
Stommel, JM ;
Wahl, GM .
EMBO JOURNAL, 2004, 23 (07) :1547-1556
[34]   Modulation of microRNA processing by p53 [J].
Suzuki, Hiroshi I. ;
Yamagata, Kaoru ;
Sugimoto, Koichi ;
Iwamoto, Takashi ;
Kato, Shigeaki ;
Miyazono, Kohei .
NATURE, 2009, 460 (7254) :529-U111
[35]  
Vassilev LT, 2004, CELL CYCLE, V3, P419
[36]   Putative Tumor Suppressor miR-145 Inhibits Colon Cancer Cell Growth by Targeting Oncogene Friend Leukemia Virus Integration 1 Gene [J].
Zhang, Jianjun ;
Guo, Haiyan ;
Zhang, He ;
Wang, Haibo ;
Qian, Guanxiang ;
Fan, Xianqun ;
Hoffman, Andrew R. ;
Hu, Ji-Fan ;
Ge, Shengfang .
CANCER, 2011, 117 (01) :86-95
[37]   MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network [J].
Zhang, Jianjun ;
Guo, Haiyan ;
Qian, Guanxiang ;
Ge, Shengfang ;
Ji, Huifeng ;
Hu, Xiaobo ;
Chen, Wantao .
MOLECULAR CANCER, 2010, 9